Addiction News and Research

RSS

State highlights: Parents of disabled kids blast Minnesota Gov.; N.Y. reins in tanning salon claims

A tearful mother, one of several who testified at a State Capitol press conference Wednesday to make an impassioned plea for a medical marijuana law, said that Gov. Mark Dayton had earlier suggested to her and others that they obtain the drug illegally.

28 Mar 2014

Longer looks: Exercise to treat depression; crowdsourcing treatment decisions; nitroglycerin shortage

Depression is the most common mental illness-;affecting a staggering 25 percent of Americans-;but a growing body of research suggests that one of its best cures is cheap and ubiquitous.

28 Mar 2014

Biodelivery Sciences collaborates with Quintiles to launch BUNAVAIL in the U.S.

BioDelivery Sciences International, Inc. announced that it has entered into an agreement with Quintiles to provide a range of services to support the anticipated launch of BUNAVAIL (buprenorphine and naloxone buccal film), BDSI's proposed maintenance treatment for opioid dependence.

27 Mar 2014

TCSPP to launch online B.A. Completion Program in Psychology in fall 2014

The Chicago School of Professional Psychology (TCSPP), the leading nonprofit national graduate school devoted exclusively to psychology and related behavioral and health sciences, will offer an online Bachelor's of Arts Completion Program in Psychology for the first time starting fall 2014.

27 Mar 2014

Research findings point to potential biomarkers for early detection of at-risk youth

Researchers at the University of California, San Diego School of Medicine have discovered impaired neuronal activity in the parts of the brain associated with anticipatory functioning among occasional 18- to 24-year-old users of stimulant drugs, such as cocaine, amphetamines and prescription drugs such as Adderall.

26 Mar 2014

Nasal spray holds promise as potential alternative therapeutic approach for depression

A nasal spray that delivers a peptide to treat depression holds promise as a potential alternative therapeutic approach, research from the Centre for Addiction and Mental Health (CAMH) shows.

25 Mar 2014

Study: Role of alcohol in U.S. traffic deaths may be underreported on death certificates

It's no secret that drinking and driving can be a deadly mix. But the role of alcohol in U.S. traffic deaths may be substantially underreported on death certificates, according to a study in the March issue of the Journal of Studies on Alcohol and Drugs.

24 Mar 2014

Drug and alcohol abuse could be linked with poor development of "love hormone"

Addictive behavior such as drug and alcohol abuse could be associated with poor development of the so-called "love hormone" system in our bodies during early childhood, according to researchers at the University of Adelaide.

21 Mar 2014

Playing science-based mobile gaming app for 25 minutes can reduce anxiety

Playing a science-based mobile gaming app for 25 minutes can reduce anxiety in stressed individuals, according to research published in Clinical Psychological Science, a journal of the Association for Psychological Science.

19 Mar 2014

Prescriptions of opioid analgesics increased during U.S. emergency department visits

George Washington University (GW) researchers report dramatic increases in prescriptions of opioid analgesics, such as Percocet, Vicodin, oxycodone and Dilaudid, during U.S. emergency department visits from 2001 to 2010.

18 Mar 2014

Social pressures rather than physical dangers may restrict e-cigarette use, says university professor

As part of the Psychology Invited Speakers Seminar Series at the University of Leicester, Professor Jason Hughes from the University's Department of Sociology will today argue that e-cigarettes, which are currently unregulated throughout the United Kingdom, will soon face legislation that will restrict and ban them - and that concerns about social dangers, more than physical dangers to health, will be the cause of it.

17 Mar 2014

Orexo signs multi-year agreement with OptumRx and UnitedHealth Group

Orexo AB, the manufacturer of ZUBSOLV® (buprenorphine and naloxone) sublingual tablets (CIII), announced a multi-year agreement with UnitedHealth Group® and OptumRx® providing preferred coverage and reimbursement of ZUBSOLV®.

12 Mar 2014

Researchers identify distinct profiles of brain activity present when making decisions

Although choosing to do something because the perceived benefit outweighs the financial cost is something people do daily, little is known about what happens in the brain when a person makes these kinds of decisions.

12 Mar 2014

Synta Pharmaceuticals' Hsp90 inhibitor ganetespib selected for study in I-SPY 2 TRIAL

Synta Pharmaceuticals Corp. and QuantumLeap Healthcare Collaborative today announced that Synta's lead drug candidate, the Hsp90 inhibitor ganetespib, has been selected for study in the I-SPY 2 TRIAL (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2).

11 Mar 2014

New research reveals how substance abuse problems take hold in returning veterans

Of nearly 1 million veterans who receive opioids to treat painful conditions, more than half continue to consume opioids chronically or beyond 90 days, new research says. Results presented at the 30th Annual Meeting of the American Academy of Pain Medicine reported on a number of factors associated with opioid discontinuation with the goal of understanding how abuse problems take hold in returning veterans.

10 Mar 2014

Just one drink can affect driving abilities of older drivers

You may have only had one glass of wine with dinner, but if you're 55 or older, that single serving may hit you hard enough to make you a dangerous driver.

10 Mar 2014

E-cigarettes: New route to conventional smoking and nicotine addiction for teenagers

E-cigarettes, promoted as a way to quit regular cigarettes, may actually be a new route to conventional smoking and nicotine addiction for teenagers, according to a new UC San Francisco study.

7 Mar 2014

Alkermes initiates pivotal clinical development program for treatment of MDD

Alkermes plc today announced the initiation of the pivotal clinical development program for ALKS 5461, a once-daily, oral investigational medicine with a novel mechanism of action for the adjunctive treatment of major depressive disorder (MDD).

6 Mar 2014

Study: 55% of women are passive smokers due to exposure to tobacco smoke

As shown in a study carried out by researchers at 13 research centres in Asturias, Gipuzkoa, Sabadell and Valencia, over half of non-smoking pregnant women, 55%, are passive smokers.

5 Mar 2014

Ultra-high-field MRI provides detailed views of brain area implicated in Parkinson's disease

New research shows that ultra-high-field magnetic resonance imaging (MRI) provides detailed views of a brain area implicated in Parkinson's disease, possibly leading to earlier detection of a condition that affects millions worldwide. The results of this research are published online in the journal Radiology.